How Does Fosun International Company Work?

How does Fosun International operate?

Fosun International, a global investment powerhouse, has built a robust presence across various industries by focusing on a 'health, happiness, and wealth' ecosystem. In 2024, the company achieved a total revenue of RMB 192.14 billion, showcasing its strong operational foundation and strategic direction amidst global economic shifts. With operations spanning over 35 countries, Fosun is known for its innovative approach and dedication to delivering quality products and services to families worldwide.

The company's operational framework is significantly shaped by its four primary subsidiaries: Yuyuan, Fosun Pharma, Fosun Insurance Portugal, and Fosun Tourism Group. These entities collectively contributed RMB 134.65 billion in 2024, representing 70.1% of the total revenue. This demonstrates the integrated yet diversified nature of Fosun's business, which encompasses critical sectors like pharmaceuticals, insurance, tourism, and consumer goods. Understanding how Fosun International operates provides valuable insights into its resilient business model and its capacity for long-term value creation in a constantly changing global market.

Fosun International's business model is characterized by strategic investments and acquisitions aimed at building a comprehensive ecosystem. The company actively manages its diverse portfolio, seeking synergies between its various holdings to enhance overall performance. This approach allows Fosun to leverage its global network and capital for expansion, integrating acquired companies to strengthen its market position. The core values guiding Fosun International's operations emphasize innovation and a commitment to improving people's lives through its offerings.

The company's strategy involves identifying and investing in businesses that align with its 'health, happiness, and wealth' philosophy. Fosun International's main business segments are strategically developed to cater to evolving consumer needs. For instance, Fosun Pharma plays a crucial role in the health sector, while Fosun Tourism Group addresses the happiness aspect. The company's financial reporting practices are transparent, detailing its revenue generation across these diverse businesses. Fosun International's approach to mergers and acquisitions is a key driver of its growth, enabling it to enter new markets and expand its service offerings.

The operational framework of Fosun International is designed for adaptability and long-term growth. The company's geographical focuses are global, with a significant presence in key international markets. Fosun International's investments are carefully managed to ensure sustainable returns and strategic alignment. The company's ability to manage its diverse portfolio effectively is a testament to its robust management structure and clear strategic vision. Exploring the Fosun International BCG Matrix can offer further insight into how the company categorizes and manages its various business units.

Fosun International operates on a unique integrated ecosystem model, focusing on 'health, happiness, and wealth' to deliver a broad spectrum of products and services to families worldwide. This strategy allows the company to create and deliver value across multiple essential life domains, catering to diverse consumer needs. The company's approach emphasizes synergy between its various business segments, aiming to provide comprehensive solutions that enhance the quality of life for its customers.

The core of Fosun International's operations is built around leveraging global capabilities with local execution. This 'global organization + local operations' model is fundamental to how Fosun International operates, enabling it to adapt to diverse market conditions while benefiting from centralized expertise and resources. This strategic framework is a key component of the Fosun International business model, driving its expansion and operational effectiveness across its international footprint.

Health Segment: Pharmaceutical Innovation

In the health sector, Fosun Pharma is a significant entity, concentrating on the research, development, manufacturing, and commercialization of pharmaceutical products. This includes a strong focus on innovative drugs and biosimilars, reflecting a commitment to advancing healthcare solutions. The company's dedication to technological advancement is substantial, with approximately RMB 6.9 billion invested in technology innovation in 2024, supported by over 20 global technology innovation centers.

Happiness Segment: Lifestyle and Leisure

The happiness segment spans tourism, leisure, fashion, consumer goods, and lifestyle industries, with key contributors like Club Med and Yuyuan. Club Med reported a record business volume of RMB 16.15 billion in 2024, showcasing robust growth across various regions. Yuyuan's cultural initiatives, such as its well-known lantern festivals, are expanding internationally, fostering cultural exchange in new markets.

Wealth Segment: Financial Services Growth

Within the wealth segment, Fosun Insurance Portugal has demonstrated considerable growth in both domestic and international markets, with total gross written premiums reaching approximately EUR 6.17 billion in 2024. Pramerica Fosun Life Insurance also experienced a significant increase in its total premium income, reaching RMB 9.251 billion in 2024, highlighting the segment's expansion.

Value Proposition: Holistic Family Solutions

Fosun International's value proposition lies in its ability to offer a comprehensive ecosystem that addresses varied family needs, differentiating it from competitors through a holistic approach. This integrated model provides customers with a wide array of products and services designed to enhance their health, happiness, and wealth, creating a distinct market advantage.

Operational Effectiveness and Global Reach

Fosun's operational effectiveness is significantly driven by its 'global organization + local operations' model. This framework allows the company to harness global capabilities while maintaining strong local relevance and market penetration. The company's overseas revenue grew by 6.2% year-on-year in 2024, accounting for 49.3% of its total revenue, underscoring its successful global expansion and integration strategies. This global network supports its diverse portfolio and is a key aspect of Target Market of Fosun International.

• Globally integrated supply chain and distribution networks.
• Leveraging global capabilities with local operational execution.
• Overseas revenue contributed 49.3% to total revenue in 2024.
• Focus on innovation across all business segments.

Complete Fosun International Strategy Bundle

• 6 Full Frameworks, 1 Company – All Pre-Researched
• Each Framework Fully Sourced with Real Company Data
• Built for Strategy Courses, Case Studies & MBA Programs
• Adapt to Your Assignment – No Starting from Scratch
• 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's

GET FULL BUNDLE

Fosun International's revenue generation is deeply rooted in its diversified business segments, primarily focusing on health, happiness, wealth, and intelligent manufacturing. In 2024, the company achieved a significant total revenue of RMB 192.14 billion. A substantial portion of this revenue, 70.1% or RMB 134.65 billion, was contributed by its four key subsidiaries: Yuyuan, Fosun Pharma, Fosun Insurance Portugal, and Fosun Tourism Group, illustrating the operational framework of Fosun International.

The 'happiness' segment stands out as the largest revenue contributor. Within this, Club Med, a prominent entity in tourism and leisure, reported a business volume of RMB 16.15 billion in 2024. The 'health' segment, spearheaded by Fosun Pharma, posted operating revenue of RMB 41.07 billion in 2024. Notably, its subsidiary Henlius saw its overseas product sales revenue reach RMB 121 million, marking a robust year-on-year increase of 30.76%. The 'wealth' segment, particularly Fosun Insurance Portugal, collected total gross written premiums of approximately EUR 6.17 billion in 2024, with overseas revenue climbing to EUR 1.84 billion. Pramerica Fosun Life Insurance also experienced substantial growth, with total premium income rising from RMB 4.346 billion in 2023 to RMB 9.251 billion in 2024, showcasing the Fosun International business model's effectiveness.

Fosun International employs a multi-faceted monetization strategy that includes direct product sales, such as pharmaceuticals and consumer goods, alongside service fees derived from its tourism and healthcare operations. The insurance businesses contribute significantly through premiums. The company actively pursues an 'asset-light' approach to manage its diverse portfolio and optimize its investments. An example of this strategy is Fosun Pharma's establishment of a RMB 5.0 billion biopharmaceutical industry fund in 2024, fostering industry development. Furthermore, the company completed asset divestments amounting to approximately RMB 17.5 billion in 2024, a move aimed at enhancing liquidity and strengthening its financial position. This strategic approach of 'business streamlining and advancements and exits' allows Fosun to concentrate on core areas like household consumption, thereby reinforcing its stable operational fundamentals. The increasing proportion of overseas revenue, which reached 49.3% of total revenue in 2024, highlights the success of its globalization strategy as a new growth engine for Fosun International.

Health Segment Performance

Fosun Pharma's operating revenue reached RMB 41.07 billion in 2024. Henlius, a subsidiary, saw a 30.76% year-on-year increase in overseas product sales revenue, reaching RMB 121 million.

Happiness Segment Contribution

The 'happiness' segment is the largest revenue generator. Club Med, a key tourism and leisure asset, achieved a business volume of RMB 16.15 billion in 2024.

Wealth Segment Growth

Fosun Insurance Portugal reported total gross written premiums of approximately EUR 6.17 billion in 2024. Pramerica Fosun Life Insurance's premium income surged to RMB 9.251 billion in 2024.

Asset-Light Strategy

Fosun Pharma established a RMB 5.0 billion biopharmaceutical industry fund in 2024. Asset divestments amounted to approximately RMB 17.5 billion in 2024.

Globalization as a Growth Engine

Overseas revenue accounted for 49.3% of total revenue in 2024. This demonstrates successful globalization efforts as a key driver for Fosun International's growth.

Revenue Diversification

Fosun International generates revenue through product sales, service fees, and insurance premiums. This diverse approach supports its stable operational fundamentals.

Key Financial Highlights and Strategic Focus

Fosun International's overall revenue in 2024 reached RMB 192.14 billion, with its core subsidiaries contributing 70.1%. The company's strategy emphasizes business streamlining and selective exits to optimize its asset portfolio, particularly focusing on household consumption. This approach, combined with a growing global presence, underpins its financial performance and operational framework.

• Total Revenue (2024): RMB 192.14 billion
• Core Subsidiaries Revenue Contribution (2024): RMB 134.65 billion (70.1% of total)
• Club Med Business Volume (2024): RMB 16.15 billion
• Fosun Pharma Operating Revenue (2024): RMB 41.07 billion
• Fosun Insurance Portugal Gross Written Premiums (2024): Approx. EUR 6.17 billion
• Pramerica Fosun Life Insurance Premium Income Growth (2023-2024): From RMB 4.346 billion to RMB 9.251 billion
• Overseas Revenue Proportion (2024): 49.3% of total revenue
• Asset Divestments (2024): Approx. RMB 17.5 billion
• Fosun Pharma Biopharmaceutical Fund: RMB 5.0 billion

From PESTLE Factors to Full Strategy Bundle

• PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
• Every Strategic Angle Covered – Nothing Left to Research
• Pre-filled with Company-Specific Research
• No Missing Sections for Your Case Study
• One Download Covers Your Entire Company Analysis

GET COMPLETE BUNDLE

Fosun International has strategically focused on streamlining its operations and divesting non-core assets throughout 2024, a move that generated approximately RMB 17.5 billion in asset sales at the group level. This initiative is designed to sharpen the company's focus on the household consumption sector and bolster its financial standing. A significant financial milestone was achieved in November 2024 when Fosun successfully re-entered the offshore USD bond market after a three-year hiatus, issuing long-duration bonds to diversify its financing avenues and enhance its credit profile, a move supported by S&P's stable outlook.

Operationally, the company's pharmaceutical arm, Fosun Pharma, demonstrated robust performance in 2024, reporting a net profit of RMB 820 million, marking a substantial 50.3% year-on-year increase. This growth was fueled by the successful approval of innovative drugs and biosimilars. A notable achievement was the EU approval in early 2025 for HANSIZHUANG, a self-developed drug, for the first-line treatment of extensive-stage small cell lung cancer, making it the first PD-1 innovative drug to reach this market. Furthermore, Fosun launched the ULTRAMED Hainan project in Sanya in 2024, and in the tourism sector, shareholders approved the privatization of Fosun Tourism Group (FTG) in 2024, granting FTG increased autonomy for accelerated development.

Fosun's competitive edge is built upon its diversified 'health, happiness, and wealth' ecosystem, offering a comprehensive value proposition to families worldwide. The company's commitment to technological innovation is evident in its investment of approximately RMB 6.9 billion in 2024 and the establishment of over 20 global technology innovation centers, which are crucial for its product and service development. The 'global organization + local operations' strategy has been instrumental in driving overseas revenue, which constituted 49.3% of total revenue in 2024, serving as a key growth driver and a buffer against macroeconomic fluctuations. Fosun also maintains strong Environmental, Social, and Governance (ESG) credentials, including an MSCI ESG rating of AA since 2021 and a ranking in the top 5% of global peers in S&P Global's Corporate Sustainability Assessment as of December 2024, reinforcing its brand strength and investor appeal. The company continues to adapt by prioritizing innovation, embracing asset-light operational models, and executing strategic divestments to optimize its business portfolio.

Strategic Divestments and Focus on Consumption

In 2024, Fosun International executed a strategy of 'business streamlining and advancements and exits.' This involved divesting non-core assets, generating approximately RMB 17.5 billion in sales. The primary goal was to enhance liquidity and strengthen the balance sheet, with a clear aim to deepen its focus on the household consumption sector.

Return to Offshore Bond Market and Financial Health

November 2024 marked Fosun's return to the offshore USD bond market after a three-year absence. The issuance of long-duration bonds aimed to expand financing options and improve its credit profile. S&P maintained a stable outlook, reflecting confidence in the company's financial strategy.

Pharmaceutical Advancements and Global Reach

Fosun Pharma achieved sustained profitability in 2024 with a net profit of RMB 820 million, a 50.3% increase year-on-year. Key drivers included approvals for innovative drugs like HANSIZHUANG, which received EU approval in early 2025 for extensive-stage small cell lung cancer treatment, marking a significant global milestone.

Tourism Sector Privatization and Operational Flexibility

Shareholders approved the privatization of Fosun Tourism Group (FTG) in 2024. This move is expected to provide FTG with greater flexibility to pursue accelerated development and strategic initiatives within the tourism industry.

Fosun's Competitive Strengths and Global Strategy

Fosun's competitive advantages are deeply embedded in its diversified 'health, happiness, and wealth' ecosystem, offering a holistic value proposition to families globally. The company's strategic emphasis on innovation and global expansion, as detailed in its Brief History of Fosun International, underpins its operational framework.

• Significant investment in technology innovation, totaling approximately RMB 6.9 billion in 2024.
• Establishment of over 20 global technology innovation centers to drive product and service development.
• 'Global organization + local operations' strategy, with overseas revenue reaching 49.3% of total revenue in 2024.
• Strong ESG ratings, including an MSCI ESG rating of AA since 2021 and a top 5% ranking in S&P Global's Corporate Sustainability Assessment as of December 2024.

Fosun International Business Model + Strategy Bundle

• Ideal for Essays, Case Studies & Slides
• Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
• Company-Specific Content Already Organized
• One Bundle Replaces Days of Independent Research
• Buy the Bundle Once. Use Across All Your Assignments

GET COMPLETE ANALYSIS

Fosun International operates as a global innovation-driven consumer group with a significant market presence across health, happiness, wealth, and intelligent manufacturing. As of December 2024, the company demonstrated strong sustainability credentials, ranking in the top 5% among global peers in S&P Global's Corporate Sustainability Assessment (CSA) within the industrial conglomerates sector. Its global reach is substantial, with overseas revenue accounting for 49.3% of its total revenue in 2024, highlighting its reliance on international operations as a key growth driver. The company's strategic emphasis on household consumption and its integrated ecosystem of businesses foster customer loyalty across its varied segments, illustrating a core aspect of the Fosun International business model.

The operational framework of Fosun International is characterized by its diverse portfolio and global footprint. The company's approach to managing its diverse portfolio involves strategic investments and acquisitions aimed at building synergistic business clusters. This strategy allows Fosun International to generate revenue across its businesses by leveraging cross-sectoral opportunities and operational efficiencies. The governance structure of Fosun International is designed to oversee these varied operations, ensuring alignment with its overarching strategic objectives.

Industry Position

Fosun International holds a leading position as a global innovation-driven consumer group. Its strong performance in sustainability assessments and significant overseas revenue underscore its robust global standing. The company's focus on household consumption and its integrated business ecosystem are key elements of its market approach.

Key Risks and Challenges

The company faces risks from global economic fluctuations and market volatility, as noted in its 2024 financial reporting. Intensified competition and regulatory changes in its diverse operating markets present ongoing challenges. Geopolitical tensions and evolving consumer preferences also pose potential impacts on specific business segments.

Future Outlook and Strategy

Management is confident in achieving steady development by focusing on core industries and leveraging globalization and innovation. The company's strategy includes optimizing its asset portfolio and reducing debt through business streamlining. Fosun aims for enhanced profitability with a target of RMB 10 billion in future industrial operation profit.

Growth Drivers and Investments

Technological innovation is a key driver, with approximately RMB 6.9 billion invested in technology innovation in 2024, including the establishment of global technology innovation centers. The company plans to double its Club Med resorts by 2026, aligning with global travel recovery trends, demonstrating how Fosun International utilizes its capital for expansion and its approach to mergers and acquisitions.

Fosun International's Strategic Focus

Fosun International's strategy is centered on deepening its focus on core industries and enhancing its global operational capabilities. The company is committed to innovation and portfolio optimization to generate long-term, stable value for shareholders.

• Deepening focus on core industries
• Leveraging globalization and innovation
• Optimizing asset portfolio and reducing debt
• Investing in technological innovation
• Expanding global presence in key sectors

From Five Forces to Full Company Analysis

• Includes SWOT, PESTLE, BMC, BCG and 4P's
• Pre-Researched with Company-Specific Data
• Best Value for a Complete Analysis
• Ready to Adapt for Your Case Study
• Ready for Essays and Slidesd

GET FULL BUNDLE